INTRODUCE YOUR PATIENTS TO VISBIOME®
Visbiome® and Visbiome® Extra Strength are high potency probiotic medical foods, as defined by the Orphan Drug Act and additional FDA regulations.
Visbiome contains the De Simone Formulation, a blend of 8 strains of live bacteria, one of the few probiotic preparations that has undergone rigorous double-blind, placebo-controlled scientific trials.
,Visbiome® aids in the dietary management of dysbiosis associated with:
- Irritable Bowel Syndrome (IBS)
- Ulcerative Colitis
- Pouchitis
- Hepatic Encephalopathy (HE)
The De Simone Formulation in Visbiome® and Visbiome® Extra Strength is one of the few probiotic preparations that has undergone rigorous, double-blind, placebo-controlled scientific trials.
An eight-strain cocktail cultured from Master Cell Banks in specific strain ratios.
|
Genus |
Species |
Deposit References |
|---|---|---|
| Lactobacillus | paracasei | DSM 24733/SD5218 |
| Lactobacillus | plantarum | DSM 24730/SD5209 |
| Lactobacillus | acidophilus | DSM 24735/SD5212 |
| Lactobacillus | delbrueckii subspecies bulgaricus* | DSM 24734/SD5210 |
| Bifidobacterium | longum± | DSM 24736/SD5220 |
| Bifidobacterium | infantis± | DSM 24737/SD5219 |
| Bifidobacterium | breve | DSM 24732/SD5206 |
| Streptococcus | thermophilus | DSM 24731/SD5207 |
|
Genus |
Species |
Deposit References |
|---|---|---|
| Lactobacillus | paracasei | DSM 24733/SD5218 |
| Lactobacillus | plantarum | DSM 24730/SD5209 |
| Lactobacillus | acidophilus | DSM 24735/SD5212 |
| Lactobacillus | delbrueckii subspecies bulgaricus* | DSM 24734/SD5210 |
| Bifidobacterium | longum± | DSM 24736/SD5220 |
| Bifidobacterium | infantis± | DSM 24737/SD5219 |
| Bifidobacterium | breve | DSM 24732/SD5206 |
| Streptococcus | thermophilus | DSM 24731/SD5207 |
± Reclassified as Bifidobacterium lactis
* Reclassified as Lactobacillus helveticus
Visbiome® is intended for use under the supervision of a trained physician, and is available in the following forms:
Visbiome Capsules
Bacteria Count
(CFUs per capsule)
112.5
Billion
Visbiome Unflavored
Bacteria Count
(CFUs per packet)
450
Billion
Visbiome Extra Strength
Bacteria Count
(CFUs per packet)
900
Billion
Visbiome® Capsule
Visbiome
Capsule
Bacteria Count
(CFUs per capsule)
112.5
Billion
Visbiome® Unflavored Powder
Bacteria Count
(CFUs per packet)
450
Billion
Visbiome® Extra Strength
Bacteria Count
(CFUs per packet)
900
Billion
What You – and Your Patients – Should Know
Drug Interactions:
While there are no known adverse drug interactions associated with the consumption of Visbiome®, some strains of bacterium may be inactivated by certain antibiotics. Advise your patients not to consume Visbiome® within 4 hours after taking antibiotics.
Side Effects:
The most reported side effect associated with Visbiome® is mild abdominal bloating, typically within the first few days of taking the probiotic. The bloating – which is generally a physiological adaptation of the microflora – typically diminishes within 3-4 days. If bloating persists, reduce your patient’s intake for a few days.
Other Precautions:
Visbiome® and Visbiome® Extra Strength should be kept out of the reach of children and should not be used in premature infants in the Neonatal Intensive Care Unit (NICU) setting. Additionally, consult with patients who are pregnant or lactating before they consider using Visbiome or any other medical food product.
Offer Your Patients Relief.
Offer Them Visbiome®.
To set up a Professional Sampling Program account
fill out the form below:
The Visbiome® Professional Sampling Program is available to medical professionals. If you would like to set up a professional sampling account, please fill out the following application below. ExeGi Pharma will contact you within 1-2 business days to finalize the account setup.
ExeGi Pharma Customer Service:
Phone: (844) FIT-GUTS
(844) 348-4887
Email: info@ExeGiPharma.com
Corporate Website: www.ExeGiPharma.com